Addex Therapeutics (ADXN) Invested Capital: 2022-2025
Historic Invested Capital for Addex Therapeutics (ADXN) over the last 1 years, with Jun 2025 value amounting to -$430.8 million.
- Addex Therapeutics' Invested Capital fell 11.12% to -$430.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$430.8 million, marking a year-over-year decrease of 11.12%. This contributed to the annual value of $11.0 million for FY2024, which is 762.48% up from last year.
- As of Q2 2025, Addex Therapeutics' Invested Capital stood at -$430.8 million, which was down 9.16% from -$394.7 million recorded in Q1 2025.
- Addex Therapeutics' 5-year Invested Capital high stood at $11.0 million for Q4 2024, and its period low was -$430.8 million during Q2 2025.
- Moreover, its 3-year median value for Invested Capital was -$391.2 million (2025), whereas its average is -$269.6 million.
- In the last 5 years, Addex Therapeutics' Invested Capital tumbled by 74.68% in 2023 and then spiked by 755.45% in 2024.
- Addex Therapeutics' Invested Capital (Quarterly) stood at $5.1 million in 2022, then plummeted by 74.68% to $1.3 million in 2023, then spiked by 755.45% to $11.0 million in 2024, then fell by 11.12% to -$430.8 million in 2025.
- Its last three reported values are -$430.8 million in Q2 2025, -$394.7 million for Q1 2025, and $11.0 million during Q4 2024.